Institution Information
Reportee Signature Date Report period Total Entries Total Value($)
OMEGA FUND MANAGEMENT LLC 07-12-2019 06-30-2019 15 392,077,000
Institutional Holdings
Issuer Class Position Value Shares Portfolio Percentage (%) Previous Percentage (%) Shares Delta Shares Delta(%)
Gossamer Bio Common Stock 1 $154,227,000 6,953,416 39.34 6,953,416 +Inf
Replimune Group Common Stock 2 $74,567,000 5,103,455 19.02 48.03 0 0.00
Morphic Holding Common Stock 3 $58,857,000 2,969,582 15.01 2,969,582 +Inf
Translate Bio Common Stock 4 $30,787,000 2,437,603 7.85 15.41 0 0.00
KezarLife Sciences Common Stock Liquidated $0 0 11.82 675,623 +Inf
Immunic Common Stock 6 $15,731,000 1,371,494 4.01 1,371,494 +Inf
ObsEva Common Stock 7 $11,303,000 999,364 2.88 7.93 0 0.00
Paratek Pharmaceuticals Common Stock 8 $10,376,000 2,600,410 2.65 8.65 0 0.00
Trevi Therapeutics Common Stock 9 $9,476,000 1,263,408 2.42 1,263,408 +Inf
Prevail Therapeutics Common Stock 10 $8,830,000 668,908 2.25 668,908 +Inf
CymaBay Therapeutics Common Stock Liquidated $0 0 4.54 3.22 0 0.00
FibroGen Common Stock 12 $5,903,000 130,646 1.51 4.40 0 0.00
Pieris Pharmaceuticals Common Stock 13 $3,546,000 754,457 0.90 1.62 -23,773 -3.05
ESSA Pharma Common Stock 14 $2,658,000 1,084,848 0.68 2.29 0 0.00
Jounce Therapeutics Common Stock 15 $2,623,000 529,965 0.67 2.04 0 0.00
Cidara Therapeutics Common Stock 16 $2,535,000 1,508,794 0.65 2.48 0 0.00
Dicerna Pharmaceuticals Common Stock Liquidated $0 0 1.52 1.32 0 0.00
Sienna Biopharmaceuticals Common Stock 18 $660,000 758,610 0.17 1.09 0 0.00
Egalet Common Stock Liquidated $0 0 0.01 2,889,926 +Inf
Debug Info- Version: 1.9